Total Valuation
Global Pharmatech has a market cap or net worth of $33.25M. The enterprise value is $33.24M.
Market Cap$33.25M
Enterprise Value$33.24M
Share Statistics
Global Pharmatech has 415,211,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding415,211,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Global Pharmatech’s return on equity (ROE) is 0.56 and return on invested capital (ROIC) is 169.86%.
Return on Equity (ROE)0.56
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)169.86%
Return on Capital Employed (ROCE)0.56
Revenue Per Employee1.43K
Profits Per Employee-312.11
Employee Count217
Asset Turnover0.41
Inventory Turnover9.90
Valuation Ratios
The current PE Ratio of Global Pharmatech is 800.9. Global Pharmatech’s PEG ratio is 15.25.
PE Ratio800.9
PS Ratio198.76
PB Ratio-513.53
Price to Fair Value-513.53
Price to FCF0.00
Price to Operating Cash Flow-300.80
PEG Ratio15.25
Income Statement
In the last 12 months, Global Pharmatech had revenue of 310.89K and earned -67.73K in profits. Earnings per share was >-0.01.
Revenue310.89K
Gross Profit34.66K
Operating Income-67.81K
Pretax Income-67.73K
Net Income-67.73K
EBITDA-59.91K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -52.26K and capital expenditures -27.68K, giving a free cash flow of -79.94K billion.
Operating Cash Flow-52.26K
Free Cash Flow-79.94K
Free Cash Flow per Share>-0.01
Dividends & Yields
Global Pharmatech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.45
52-Week Price Change-27.27%
50-Day Moving Average0.07
200-Day Moving Average0.06
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Global Pharmatech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Global Pharmatech as a current ratio of 0.44, with Debt / Equity ratio of -1000.57%
Current Ratio0.44
Quick Ratio0.41
Debt to Market Cap<0.01
Net Debt to EBITDA-0.85
Interest Coverage Ratio-113.24
Taxes
In the past 12 months, Global Pharmatech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Global Pharmatech EV to EBITDA ratio is -1.03K, with an EV/FCF ratio of 0.00.
EV to Sales198.93
EV to EBITDA-1.03K
EV to Free Cash Flow0.00
EV to Operating Cash Flow4.15K
Balance Sheet
Global Pharmatech has $106.13K in cash and marketable securities with $90.63K in debt, giving a net cash position of $15.50K billion.
Cash & Marketable Securities$106.13K
Total Debt$90.63K
Net Cash$15.50K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 26.84%, with operating margin of -21.81%, and net profit margin of -21.78%.
Gross Margin26.84%
Operating Margin-21.81%
Pretax Margin-21.78%
Net Profit Margin-21.78%
EBITDA Margin-19.27%
EBIT Margin-21.59%
Analyst Forecast
The average price target for Global Pharmatech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-32.01%
EPS Growth Forecast50.00%